Disruptive Mood Dysregulation Disorder
Disruptive mood dysregulation disorder (DMDD) is a childhood condition of extreme irritability, anger, and frequent, intense temper outbursts. DMDD symptoms go beyond a being a “moody” child—children with DMDD experience severe impairment that requires clinical attention.
Cluster Number:
Wiki Number: W066
Diagnosis: Disruptive Mood Dysregulation Disorder
US Patients: 1.5% children
World Patients:
Sex Ratio:
Age Onset: Child or adolescent
Brain Area: under-activity of the amygdala at judging other’s anger or sadness; medial front gyrus and anterior cingulate cortex – lower
Symptoms: disproportionate irritable or angry moods or several temper outbursts weekly; poor stress regulation; one year or more
Progression: displays persistent anger against people and objects, often have anxiety and depression in later years
Causes: Brain areas above are important for evaluating and regulating negative emotions; poverty and single-parenthood affect it
Medications: antidepressants, antipsychotics and mood stabilizers
Therapies: None listed.
Youtube Video: Treatment Challenges of Impulse Control
Behavioral Disorder
Amazon or Library Book:
What Were You Thinking?
Amazon or Library Book:
Teach Your Dragon Manners
Click the book to link or buy from Amazon.
Click the book to link or buy from Amazon.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Prenatal bisphenol A and/or diethylhexyl phthalate exposure followed by adult estradiol treatment affects behavior and brain monoamines in female rat offspringby Amrita Kaimal on January 22, 2025
CONCLUSIONS: Overall, prenatal EDC exposure altered behavior, hormones, and brain monoamines, with adult E2 treatment further exacerbating some of these effects in female offspring.
- The levels of the long non-coding RNA MALAT1 affect cell viability and modulate TDP-43 binding to mRNA in the nucleusby Adarsh Balaji on January 21, 2025
TAR DNA-binding protein (TDP-43) and Metastasis Associated Lung Adenocarcinoma Transcript (MALAT1) RNA are both abundantly expressed in the human cell nucleus. Increased interaction of TDP-43 and MALAT1, as well as dysregulation of TDP-43 function, was previously identified in brain samples from patients with neurodegenerative disease compared to healthy brain tissues. We hypothesized that TDP-43 function may depend in part on MALAT1 expression levels. Here, we find that alterations in MALAT1...
- Exploring temperament and sleep patterns in disruptive mood dysregulation disorder among children and adolescents: implications for clinical practiceby Helin Abursu on January 19, 2025
CONCLUSION: Children and adolescents diagnosed with DMDD demonstrated significantly lower scores in anticipatory worry, fear of uncertainty, shyness, fatigability, sentimentality, dependence, empathy, and helpfulness compared to those with MDD. Conversely, they exhibited higher levels of impulsiveness, disorderliness, and self-acceptance. These findings underscore the necessity of evaluating and enhancing social skills and reward sensitivity in the clinical management of DMDD, as these distinct...
- Pediatric Attention-Deficit/Hypearativity Disorder and Disruptive Mood Dysregulation Disorder: Analyzing National Treatment Trendsby Raman Baweja on January 19, 2025
CONCLUSIONS: In youth with ADHD, a DMDD diagnosis is associated with increases in the spectrum of pharmacological and nonpharmacological treatments deployed with patterns varying by race and ethnicity. Antipsychotic and mood stabilizer prescriptions increased most prominently, often before receiving psychotherapy services or efforts to optimize ADHD medication. Future research should address disparities in DMDD treatment patterns and identify the optimal treatment sequences for DMDD.